MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company focused on developing therapies for neurological and neuropsychiatric disorders, today announced the successful ...

MIRA Pharmaceuticals unveils Ketamir-2 topical for neuropathic pain, complementing its oral version. Clinical and preclinical ...

MIRA Pharmaceuticals (MIRA) announced the formulation of Ketamir-2 into a topical treatment for localized neuropathic and inflammatory pain.

Expert advice from Dr. Sunil Dhingra on the role of topical gels in arthritis pain management, their uses and benefits.

Research finds women, younger individuals, and those with nociplastic pain conditions like fibromyalgia are more likely to ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on a dosing initiation, a ...

U.S. researchers said Wednesday they have reproduced the pain-relieving effects of cannabis with a synthesized compound that ...

For the nearly 20% of adults battling chronic pain daily, each morning brings the same question: Will today hurt less than ...

Deadlifts are an amazing, full-body exercise that really strengthens the posterior chain (and makes those glutes pop!). But one big mistake many exercisers make with deadlifts is using the lower back ...

MIRA Pharmaceuticals gains approval for a Phase 1 trial of Ketamir-2 in Israel, aiming to complete by Q4 2025 before moving ...

Determining the source of symptoms in those with musculoskeletal pain is extremely important, as it sets the foundation for ...